# Enhanced Alarmin Secretion Exacerbates Neutrophil Extracellular Trap (NET) Formation in Active Psoriasis: Implication of IL-33 and TSLP in Driving NET Formation, Inflammation and Oxidative Stress in Psoriasis

**Authors:** Vanshika Ojha, Manoj Kumar Tembhre, Vishal Gupta

PMC · DOI: 10.3390/antiox15010071 · Antioxidants · 2026-01-06

## TL;DR

This study shows that alarmins IL-33 and TSLP increase NET formation in psoriasis, leading to more inflammation and oxidative stress.

## Contribution

The study reveals a novel mechanism linking alarmins IL-33 and TSLP to enhanced NET formation in psoriasis.

## Key findings

- Active psoriasis patients have higher neutrophil counts and NET markers compared to controls.
- IL-33 and TSLP upregulation in blood and skin correlates with increased NET formation.
- NETs primed by IL-33 and TSLP increase inflammation and oxidative stress in PBMCs.

## Abstract

Psoriasis is a common inflammatory skin disease with chronic manifestation in which the role of neutrophil extracellular traps (NETs) and alarmins are increasingly recognized as contributors to systemic and cutaneous inflammation. However, the interaction between alarmins and NET-driven immune responses remains poorly defined. The main aim of this study is to define the role of target alarmins (i.e., IL-33 and TSLP) in NETs induction and its subsequent impact on oxidative stress and inflammation in the peripheral blood. In the present study, we recruited active psoriasis patients (n = 56) and control (n = 56) subjects. The frequency of circulating neutrophils, the levels of NET-associated markers (MPO (myeloperoxidase)–DNA complex, CitH3 (citrullinated histone H3), PAD4 (peptidyl arginine deiminase4), NADPH oxidase, and NE (neutrophil elastase)), and alarmin transcripts (IL (interleukin)-33, TSLP (thymic stromal lymphopoietin), S100A7, S100B, HSP (heat shock protein) 60/70 were quantified using flow cytometry, ELISA (Enzyme-linked immunosorbent assay), and qPCR (quantitative polymerase chain reaction), respectively, in each group. The NET formation potential of isolated neutrophils was assessed in the presence or absence of rhIL-33 and rhTSLP by immunocytofluorescence. The effect of rhIL-33- and rhTSLP-primed NETs in augmenting oxidative stress and inflammation was evaluated on peripheral blood mononuclear cells (PBMCs) by ELISA. Significantly higher circulating neutrophils (p < 0.001) and levels of NET-associated markers (i.e., MPO–DNA complex, CitH3, PAD4, NADPH oxidase, and NE) were observed in active psoriasis patients compared to controls. Lesional skin exhibited strong expression of MPO (p < 0.001) compared to normal skin. The alarmins, IL-33 and TSLP, were markedly upregulated in the blood and skin (p < 0.05). The rhIL-33 and rhTSLP treated neutrophils demonstrated enhanced NETosis in patients (p < 0.001). Increased expression of inflammatory cytokines and oxidative stress markers were reported in PBMCs when incubated with rhIL-33- and rhTSLP-primed NETs. Taken together, our investigation demonstrated the novel mechanism wherein the alarmins IL-33 and TSLP exacerbate NET formation that may drive enhanced inflammation and oxidative stress in psoriasis.

## Linked entities

- **Proteins:** IL33 (interleukin 33), TSLP (thymic stromal lymphopoietin), MPO (myeloperoxidase), PADI4 (peptidyl arginine deiminase 4), ELANE (elastase, neutrophil expressed), S100A7 (S100 calcium binding protein A7), S100B (S100 calcium binding protein B), HSPD1 (heat shock protein family D (Hsp60) member 1), HSPA1A (heat shock protein family A (Hsp70) member 1A)
- **Diseases:** psoriasis (MONDO:0005083)

## Full-text entities

- **Genes:** S100B (S100 calcium binding protein B) [NCBI Gene 6285] {aka NEF, S100, S100-B, S100beta}, S100A7 (S100 calcium binding protein A7) [NCBI Gene 6278] {aka PSOR1, S100A7c}, PADI4 (peptidyl arginine deiminase 4) [NCBI Gene 23569] {aka PAD, PAD4, PADI5, PDI4, PDI5}, MPO (myeloperoxidase) [NCBI Gene 4353], HSP90B2P (heat shock protein 90 beta family member 2, pseudogene) [NCBI Gene 7190] {aka GRP94P1, GRP94b, HSP, HSPCP2, TRA1P1, TRAP1}, ELANE (elastase, neutrophil expressed) [NCBI Gene 1991] {aka ELA2, GE, HLE, HNE, NE, PMN-E}, IL33 (interleukin 33) [NCBI Gene 90865] {aka C9orf26, DVS27, IL1F11, NF-HEV, NFEHEV}, TSLP (thymic stromal lymphopoietin) [NCBI Gene 85480]
- **Diseases:** skin disease (MESH:D012871), Inflammation (MESH:D007249), Psoriasis (MESH:D011565), NET (MESH:C536657)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12837554/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12837554/full.md

## References

85 references — full list in the complete paper: https://tomesphere.com/paper/PMC12837554/full.md

---
Source: https://tomesphere.com/paper/PMC12837554